Neotropix – A Leading Biotechnology Company Committed to Making a Difference in the Lives of Cancer Patients Through Innovative Lung Cancer Treatments & Much More. Neotropix™ Inc. develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers, such as small cell lung cancer and neuroblastoma. Capitalizing on its unique sources of naturally occurring viruses that selectively target tumors, the Company has the knowledge and skills to translate these discoveries into commercial products. Neotropix is committed to discovering innovative cancer treatments that make a difference in the lives of cancer patients.